Other Events
Annual Report · ended 2026-06-30 · Rev $1.2B
Bohnen Shane transacted shares; Bohnen Shane bought 11,344 shares at $0.00 on 2026-08-17 (+3 more)
Kelderman Kim transacted shares; Kelderman Kim bought 57,590 shares at $0.00 on 2026-08-17 (+3 more)
Hippel James transacted shares; Hippel James bought 22,438 shares at $0.00 on 2026-08-17 (+3 more)
Herr Amy E. transacted shares; Herr Amy E. transacted shares (+3 more)
Crouse Steven C. transacted shares; Crouse Steven C. bought 8,702 shares at $0.00 on 2026-08-17 (+3 more)
Earnings Release; Other Events; Financial Statements
Hippel James bought 62,068 shares at $47.60 on 2026-07-29; Hippel James sold 51,024 shares at $72.03 on 2026-07-29 (+3 more)
Kelderman Kim bought 35,000 shares at $47.60 on 2026-07-28; Kelderman Kim sold 28,686 shares at $72.07 on 2026-07-28 (+3 more)
Bohnen Shane bought 448 shares at $47.60 on 2026-07-23; Bohnen Shane sold 344 shares at $71.77 on 2026-07-23 (+3 more)
8-K current report
8-K current report
Crouse Steven C. bought 600 shares of Common Stock at $N/A on 2026-06-02; Crouse Steven C. sold 216 shares of Common Stock at $49.77 on 2026-06-02; Crouse Steven C. sold 600 shares of Restricted Stock Units at $N/A on 2026-06-02; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A; Crouse Steven C. transacted N/A shares of Stock Option (right to buy) at $N/A on N/A
Herr Amy E. bought 6,636 shares of Common Stock at $47.60 on 2026-05-08; Herr Amy E. sold 6,636 shares of Common Stock at $48.28 on 2026-05-08; Herr Amy E. transacted N/A shares of Common Stock at $N/A on N/A; Herr Amy E. sold 6,636 shares of Stock Option (Right to Buy) at $N/A on 2026-05-08; Herr Amy E. transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A
Hippel James bought 62,000 shares of Common Stock at $47.60 on 2026-05-05; Hippel James sold 56,955 shares of Common Stock at $56.68 on 2026-05-05; Hippel James sold 62,000 shares of Stock Options (Right to Buy) at $N/A on 2026-05-05; Hippel James transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A; Hippel James transacted N/A shares of Performance Restricted Stock Units at $N/A on N/A
Bohnen Shane bought 8,400 shares of Common Stock at $47.60 on 2026-05-05; Bohnen Shane sold 7,055 shares of Common Stock at $56.68 on 2026-05-05; Bohnen Shane sold 8,400 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Bohnen Shane transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Bohnen Shane transacted N/A shares of Restricted Stock Units at $N/A on N/A
Kelderman Kim bought 26,692 shares of Common Stock at $47.60 on 2026-05-05; Kelderman Kim sold 23,951 shares of Common Stock at $56.68 on 2026-05-05; Kelderman Kim sold 26,692 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Kelderman Kim transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Kelderman Kim transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A
BIO-TECHNE Corp filed 10-Q on 2026-05-06
8-K current report